The Shock Academic Research Consortium is a multi-stakeholder group, including
representatives from the US Food and Drug Administration and other government agencies …

Cardiogenic shock (CS) is a life-threatening syndrome of cardiac dysfunction and systemic
hypoperfusion, with rising incidence and persistently high mortality rates. 1, 2 CS accounts …

Importance Previous studies have described the secular trends of overall heart failure (HF)
hospitalizations, but the literature describing the national trends of unique index …

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a
broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS …

Background People with severe mental illness (SMI) are at higher risk of physical health
conditions compared to the general population, however, the impact of specific underlying …

Myocardial infarction (MI) remains the leading cause of morbidity and mortality worldwide,
and novel therapeutic targets still need to be investigated to alleviate myocardial injury and …

Acute myocardial infarction with cardiogenic shock (AMI-CS) is associated with high
mortality and morbidity despite advancements in cardiovascular care. AMI-CS is associated …

Myocardial cell injury caused by myocardial ischemia and reperfusion is one of the main
causes of the occurrence and development of heart disease. Recent study has shown that …

Objective To determine the impact of socioeconomic status using median household income
within the patient's community on rate of readmission among patients with heart failure (HF) …

Background Registries show international variations in the characteristics and outcome of
patients with heart failure (HF), but national samples are rarely large, and case selection …